.Bicara Therapies and Zenas Biopharma have given fresh inspiration to the IPO market with filings th...
.Genentech will certainly close its cancer cells immunology investigation team, and unit mind and al...
.Kezar Life Sciences is dropping its unpromising phase 1 sound cyst drug as the biotech goes all-in ...
.Despite izokibep preserving its own newly found winning touch in the medical clinic, Acelyrin is no...
.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing drug pro...
.Ovid Therapeutics already revealed final month that it was trimming back its own headcount as the b...
.Eli Lilly has opened a $700 thousand R&D center in the Boston Port, enhancing its own RNA as wel...
.Just 5 months after protecting a $100 million IPO, Limitless Bio is actually laying off some staff ...
.The preliminary stages of oncology R&D aren't short of intriguing brand-new modalities, and also...
.Psychopharmacology has actually drawn three short articles regarding midstage scientific trial data...